First key stage of the PIAVE Artus project successfully completed with the payment to MyoPowers of grants and advances repayable by Bpifrance for an amount of €3.8 million.
Management team strengthening with the appointment of Michel Finance as CEO, and Professor François Laborde as Medical Director.
Positive results of the Scope clinical study validating the clinical benefit of embolization and genesis of Kardiozis technology.
Recent Comments